pentobarbital will minimize the extent or outcome of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Robust or moderate CYP3A4 inducers may well maximize charge of diazepam elimination; as a result, efficacy of diazepam may very well be reduced.